Discontinuation report GD-AMLODIPINE

Last updated on 2019-03-26 History
Report ID 66780
Drug Identification Number 02280132
Brand name GD-AMLODIPINE
Common or Proper name GD-AMLODIPINE
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMLODIPINE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 250's
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-02-28
Remaining supply date 2019-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-11-13 English Compare
v2 2018-11-13 French Compare
v3 2018-11-13 English Compare
v4 2018-11-13 French Compare
v5 2019-03-26 English Compare
v6 2019-03-26 French Compare

Showing 1 to 6 of 6